Total sales growth of 10.7% to $23.3 Billion with operational growth of 9.9%* and adjusted operational growth of 10.6%. Earnings per share of $1.37 increasing 3.0% and adjusted earnings per share of $2.60 increasing 18.2%.

Dublin-based diagnostics firm Trinity Biotech on Thursday reported a 61 percent year-over-year increase in second quarter revenues, driven in part by sales of its PCR viral transport media for SARS-CoV-2 testing.

BioMérieux reported sales growth of 7 percent for the first half of 2021.The Marcy l'Etoile, France-based diagnostics firm reported total sales of €1.57 billion ($1.86 billion) for the six-month period ended June 30, 2020, up from €1.48 billion for the first half of 2020.

As of the end of August 2021, the first-half reports of IVD-related listed companies have basically been released. 64 IVD-related listed companies have achieved steady growth in the first half of 2021, and more than 70% of companies have shown positive growth in net profits.

Companies that have already registered their devices in the EU will still be able to sell their products in Great Britain until June 2023. From this point, they will be required to register their device for UK Conformity Assessed (UKCA) marking.

Recently, Huawei is approved of sales of wrist ECG collector. Combined the technology with wearable device, new series of smart watch was launched and could be used for measuring blood pressure.

Medtronic topped estimates in its latestearnings, fueled by sales from valves and diabetes products. For theDublin-based companys 4Q18 earnings it brought in about $8.14 billion, a 6.5percent increase. The firms Cardiac and Vascular group (